Advertisement
Screener

CALYPTE BIOMEDICAL CORP Income (Loss) from Continuing Operations, Per Basic Share

CALYPTE BIOMEDICAL CORP Income (Loss) from Continuing Operations, Per Basic Share

CALYPTE BIOMEDICAL CORP reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.00 per share for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-22.

Discontinued › Expense Statement › Operating Expenses

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2012-03-22

  • CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, per basic share for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
  • CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, per basic share for the quarter ending 2011-06-30 was -$0.00.
  • CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, per basic share for the quarter ending 2010-09-30 was $0.02.
  • CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, per basic share for the quarter ending 2010-06-30 was -$0.00.
  • CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, per basic share for fiscal 2011 was -$0.00, a 105.26% decline from fiscal 2010.
  • CALYPTE BIOMEDICAL CORP income (loss) from continuing operations, per basic share for fiscal 2010 was $0.02.
Period endIncome (Loss) from Continuing Operations, Per Basic Share 3 monthIncome (Loss) from Continuing Operations, Per Basic Share 6 monthIncome (Loss) from Continuing Operations, Per Basic Share 9 monthIncome (Loss) from Continuing Operations, Per Basic Share 12 month
2011-12-31-$0.00
10-K · filed 2012-03-22
2011-09-30$0.00
10-Q · filed 2012-01-27
-$0.00
10-Q · filed 2012-01-27
2011-06-30-$0.00
10-Q/A · filed 2011-11-30
$0.00
10-Q/A · filed 2011-11-30
2010-12-31$0.02
10-K · filed 2012-03-22
2010-09-30$0.02
10-Q · filed 2012-01-27
$0.02
10-Q · filed 2012-01-27
2010-06-30-$0.00
10-Q/A · filed 2011-11-30
-$0.00
10-Q/A · filed 2011-11-30